Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:VYX - US62886E1082 - Common Stock

9.86 USD
-0.34 (-3.33%)
Last: 1/2/2026, 8:04:00 PM
9.86 USD
0 (0%)
After Hours: 1/2/2026, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, VYX scores 3 out of 10 in our fundamental rating. VYX was compared to 276 industry peers in the Software industry. VYX may be in some trouble as it scores bad on both profitability and health. VYX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year VYX was profitable.
In the past year VYX has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: VYX reported negative net income in multiple years.
VYX had a positive operating cash flow in 4 of the past 5 years.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

VYX has a Return On Assets (-1.52%) which is in line with its industry peers.
VYX has a Return On Equity (-5.43%) which is comparable to the rest of the industry.
The Return On Invested Capital of VYX (3.31%) is better than 69.93% of its industry peers.
Industry RankSector Rank
ROA -1.52%
ROE -5.43%
ROIC 3.31%
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of VYX has grown nicely.
VYX has a better Operating Margin (4.57%) than 67.03% of its industry peers.
VYX's Operating Margin has declined in the last couple of years.
The Gross Margin of VYX (22.76%) is worse than 80.80% of its industry peers.
VYX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.57%
PM (TTM) N/A
GM 22.76%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VYX is destroying value.
VYX has less shares outstanding than it did 1 year ago.
VYX has more shares outstanding than it did 5 years ago.
VYX has a better debt/assets ratio than last year.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.27, we must say that VYX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VYX (1.27) is comparable to the rest of the industry.
VYX has a Debt/Equity ratio of 0.98. This is a neutral value indicating VYX is somewhat dependend on debt financing.
VYX has a worse Debt to Equity ratio (0.98) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.27
ROIC/WACC0.32
WACC10.26%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

VYX has a Current Ratio of 1.13. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.13, VYX is doing worse than 69.20% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that VYX may have some problems paying its short term obligations.
VYX's Quick ratio of 0.94 is on the low side compared to the rest of the industry. VYX is outperformed by 77.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.94
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 235.00% over the past year.
VYX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.03% yearly.
The Revenue for VYX has decreased by -61.25% in the past year. This is quite bad
VYX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.39% yearly.
EPS 1Y (TTM)235%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-101.95%
Revenue 1Y (TTM)-61.25%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-3.8%

3.2 Future

The Earnings Per Share is expected to grow by 27.36% on average over the next years. This is a very strong growth
Based on estimates for the next years, VYX will show a decrease in Revenue. The Revenue will decrease by -8.73% on average per year.
EPS Next Y101.34%
EPS Next 2Y53.66%
EPS Next 3Y27.36%
EPS Next 5YN/A
Revenue Next Year-7.17%
Revenue Next 2Y-11.75%
Revenue Next 3Y-8.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

VYX is valuated correctly with a Price/Earnings ratio of 12.17.
Compared to the rest of the industry, the Price/Earnings ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 86.23% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.60. VYX is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.49, the valuation of VYX can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 87.68% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of VYX to the average of the S&P500 Index (23.23), we can say VYX is valued rather cheaply.
Industry RankSector Rank
PE 12.17
Fwd PE 9.49
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

VYX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VYX is cheaper than 93.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.3
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VYX's earnings are expected to grow with 27.36% in the coming years.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y53.66%
EPS Next 3Y27.36%

0

5. Dividend

5.1 Amount

No dividends for VYX!.
Industry RankSector Rank
Dividend Yield 0%

NCR VOYIX CORP

NYSE:VYX (1/2/2026, 8:04:00 PM)

After market: 9.86 0 (0%)

9.86

-0.34 (-3.33%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners114.29%
Inst Owner ChangeN/A
Ins Owners0.43%
Ins Owner Change-3.16%
Market Cap1.37B
Revenue(TTM)2.65B
Net Income(TTM)-61.00M
Analysts85
Price Target16.03 (62.58%)
Short Float %17.51%
Short Ratio11.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP-22.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.58%
Min EPS beat(2)38.46%
Max EPS beat(2)44.71%
EPS beat(4)4
Avg EPS beat(4)94.55%
Min EPS beat(4)38.46%
Max EPS beat(4)239.46%
EPS beat(8)6
Avg EPS beat(8)41.31%
EPS beat(12)8
Avg EPS beat(12)31.35%
EPS beat(16)11
Avg EPS beat(16)21.93%
Revenue beat(2)2
Avg Revenue beat(2)1.38%
Min Revenue beat(2)1.11%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.51%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.66%
Revenue beat(8)4
Avg Revenue beat(8)-2.13%
Revenue beat(12)6
Avg Revenue beat(12)7.55%
Revenue beat(16)7
Avg Revenue beat(16)5.03%
PT rev (1m)-1.79%
PT rev (3m)-1.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.15%
EPS NY rev (1m)11.03%
EPS NY rev (3m)11.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.08%
Revenue NY rev (1m)1.28%
Revenue NY rev (3m)1.28%
Valuation
Industry RankSector Rank
PE 12.17
Fwd PE 9.49
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB N/A
EV/EBITDA 6.3
EPS(TTM)0.81
EY8.22%
EPS(NY)1.04
Fwd EY10.54%
FCF(TTM)-4.34
FCFYN/A
OCF(TTM)-3.18
OCFYN/A
SpS19.13
BVpS8.12
TBVpS-3.51
PEG (NY)0.12
PEG (5Y)N/A
Graham Number12.16
Profitability
Industry RankSector Rank
ROA -1.52%
ROE -5.43%
ROCE 4.19%
ROIC 3.31%
ROICexc 3.67%
ROICexgc 9.58%
OM 4.57%
PM (TTM) N/A
GM 22.76%
FCFM N/A
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-36.27%
ROICexgc growth 5Y-25.75%
ROICexc growth 3Y-36.4%
ROICexc growth 5Y-30.51%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
F-Score1
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 3.1
Cap/Depr 69.1%
Cap/Sales 6.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.94
Altman-Z 1.27
F-Score1
WACC10.26%
ROIC/WACC0.32
Cap/Depr(3y)67.44%
Cap/Depr(5y)68.37%
Cap/Sales(3y)8.12%
Cap/Sales(5y)6.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)235%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-101.95%
EPS Next Y101.34%
EPS Next 2Y53.66%
EPS Next 3Y27.36%
EPS Next 5YN/A
Revenue 1Y (TTM)-61.25%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-3.8%
Revenue Next Year-7.17%
Revenue Next 2Y-11.75%
Revenue Next 3Y-8.73%
Revenue Next 5YN/A
EBIT growth 1Y-27.11%
EBIT growth 3Y-58.63%
EBIT growth 5Y-42.48%
EBIT Next Year373.52%
EBIT Next 3Y79.51%
EBIT Next 5Y46.94%
FCF growth 1Y-216.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-148.35%
OCF growth 3YN/A
OCF growth 5YN/A

NCR VOYIX CORP / VYX FAQ

Can you provide the ChartMill fundamental rating for NCR VOYIX CORP?

ChartMill assigns a fundamental rating of 3 / 10 to VYX.


What is the valuation status for VYX stock?

ChartMill assigns a valuation rating of 6 / 10 to NCR VOYIX CORP (VYX). This can be considered as Fairly Valued.


Can you provide the profitability details for NCR VOYIX CORP?

NCR VOYIX CORP (VYX) has a profitability rating of 3 / 10.


What is the valuation of NCR VOYIX CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NCR VOYIX CORP (VYX) is 12.17 and the Price/Book (PB) ratio is 1.21.


What is the financial health of NCR VOYIX CORP (VYX) stock?

The financial health rating of NCR VOYIX CORP (VYX) is 2 / 10.